- Home
- Equipment
- north america
- combination seasonal influenza vaccine
Show results for
Refine by
Combination Seasonal Influenza Vaccine Equipment Supplied In North America
7 equipment items found
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both ...
Manufactured by:Merck Animal Health based inRahway, NEW JERSEY (USA)
Novel ready-to-use combination vaccines that immunizes pigs against nine different species of bacteria including Canicola, Icterohaemorrhagiae, Grippotyphosa, Australis (Bratislava), Pomona and ...
Manufactured by:Merck Animal Health based inRahway, NEW JERSEY (USA)
Ready-to-use, combined-dose vaccine against Porcine Circovirus type 2 and Mycoplasma ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Our recombinant nanoparticle vaccine technology combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic particles that target a variety of viral pathogens. Our recombinant vaccine engineering takes a new approach to provide robust and functional immunity, which may be more efficacious than naturally occurring immunity or traditional vaccines. ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines has also developed a GeneVax prime/VesiculoVax boost therapeutic vaccine that targets all eight HBV genotypes for use as an adjunct to drug ...
Manufactured by:Boehringer Ingelheim Animal Health USA Inc. based inDuluth, GEORGIA (US) (USA)
Vetera Gold XP is a combination vaccine for horses, protecting against multiple diseases in a single 1 mL dose. It is effective for healthy horses aged 4 months or older, including pregnant mares. The vaccine protects against Eastern and Western equine encephalomyelitis (EEE & WEE), West Nile virus (WNV), tetanus, equine herpesvirus types 1 and 4 (EHV-1 & EHV-4), and equine influenza ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest ...